How Do You Choose The Right Frontline Therapy in CLL Care?ByTalha Munir, MBChB, PhDJune 21st 2026Those with TP53-mutated disease may benefit from continuous BTK inhibitor therapy, although limited-duration therapy is worthy of discussion.